News Search Results
Jan 27, 2026, 14:05 ET Anchor Line Partners Supports Stoke Therapeutics' Growth by Securing a 98,500 Square-Foot Lease in Waltham, MA
/PRNewswire/ -- Anchor Line Partners, LLC and Northwood Investors, LLC announced today that they have secured a significant long-term lease with biotechnology company Stoke Therapeutics (Nasdaq: STOK) at 245 Fifth Avenue in Waltham, Massachusetts. Stoke plans to relocate to its new 98,500 square-foot headquarters
More news about: Anchor Line Partners
Jan 27, 2026, 13:09 ET MILLROCK TECHNOLOGY APPOINTS TOM HOCHULI AS CEO
team"Most recently, Mr. Hochuli served as President of a biologics-focused organization delivering cellular materials and end-to-end services to biotechnology and biopharmaceutical customers. In that role, he led a comprehensive operational and strategic transformation, improving financial performance,
More news about: Artemis
Jan 27, 2026, 12:44 ET Rubin Rudman Partner Julayne Lazar Joins Boston Cares Board of Directors
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin Rudman
Jan 27, 2026, 11:29 ET Nuveen Green Capital and Brandywine Realty Trust Close Largest C-PACE Financing in Pennsylvania History
"This investment affirms our shared commitment to growing Philadelphia as a world-class hub for growth industries, especially our life sciences and biotechnology sectors."Completed and ready for occupancy, 3151 Market is Philadelphia's next-generation innovation building, meticulously designed with
More news about: Nuveen Green Capital
Jan 27, 2026, 11:00 ET IP Attorney John Paik Joins Crowell & Moring's Patents Group
Paik joins Crowell from GRAIL, a biotechnology company, where he served as senior director and head of intellectual property. He led the protection of the company's wet lab discoveries and its
More news about: Crowell & Moring LLP
Jan 27, 2026, 10:55 ET Medical Plastic Compounds Market Surges to USD 15.8 Billion by 2033, Propelled by 5.1% CAGR - Verified Market Reports®
Kit Market Size By Product Type (PCR-Based Kits, ELISA Kits), By Application (Agricultural Testing, Food Testing), By End-User (Chemical And Biotechnology Companies, Academic And Research Institutions), By Technology (Molecular Biology Techniques, Immunological Techniques), By Distribution Channel
More news about: Verified Market Reports
Jan 27, 2026, 10:50 ET Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks
asymmetric investment window for Oncolytics Biotech Inc. (NASDAQ: ONCY), Moderna (NASDAQ: MRNA), Merck (NYSE: MRK), Vir Biotechnology (NASDAQ: VIR), and Coherus Oncology (NASDAQ: CHRS) at the intersection of pivotal execution readiness and combination immunotherapy innovation
More news about: Equity Insider
Jan 27, 2026, 10:50 ET Global Poria Cocos Extract Market Shows Strong Momentum Driven by Natural Health Trends: - Market Research Intellect
Co., Ltd., Xi'an Greena Biotech Co., Ltd., Shaanxi Jintai Biological Engineering Co., Ltd., Changsha Huir Biological-Tech Co., Ltd., Nutra Green Biotechnology Co., Ltd., and Herblink BiotechSEGMENTS
More news about: Market Research Intellect
Jan 27, 2026, 10:48 ET /C O R R E C T I O N -- BridGene Biosciences/
patients and generate substantial value in the biopharmaceutical field."About BridGene BiosciencesBridGene Biosciences is a biotechnology company pioneering the discovery and development of innovative small-molecule drugs that target traditionally undruggable targets. Leveraging its
More news about: BridGene Biosciences
Jan 27, 2026, 10:03 ET Top Cancer Researchers Join Forces to Advance Development of Therapeutic Cancer Vaccines
diagnosed with cancer in our lifetime, there's no time to waste."The think tank brings together leaders from top academic cancer centers, biotechnology and pharmaceutical companies, as well as policy and regulatory experts to establish shared priorities and actionable strategies to accelerate cancer
More news about: Cancer Vaccine Coalition
Jan 27, 2026, 10:01 ET Proteomics Market worth $65.78 Billion by 2030 | MarketsandMarkets™
in 2024.North America represents the largest regional market for proteomics. The large share is supported by the strong presence of biotechnology and pharmaceutical companies, along with sustained R&D spending across discovery and translational programs. The region also benefits from a
More news about: MarketsandMarkets
Jan 27, 2026, 09:00 ET Debut Unveils Biotech Active Delivering In-Office Skin Tightening Results in Topical Skincare
Powered by AI, skin genomics and biotechnology, Debut developed DermCeutical EDL™, the first-ever topical ingredient clinically proven to tighten and firm skin for a visibly lifted appearance.SAN DIEGO, Jan. 27,
More news about: Debut Biotechnology
Jan 27, 2026, 09:00 ET Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies
CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its
More news about: Insilico Medicine
Jan 27, 2026, 08:30 ET Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the Mexican Institute of Industrial Property (IMPI) has issued a
More news about: Anixa Biosciences, Inc.
Jan 27, 2026, 08:00 ET Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies to modulate critical RNA targets, today announces positive results from the nine month interim
More news about: Skyhawk Therapeutics
Jan 27, 2026, 08:00 ET Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies to modulate critical RNA targets, today announces positive results from the nine month interim
More news about: Skyhawk Therapeutics
Jan 26, 2026, 13:56 ET ZINZINO AB (PUBL): Zinzino announces merger of It Works! into the Zinzino family of businesses for increased distribution power in North America and Europe
strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales.It Works!, is a globally renowned direct sales company in the
More news about: Zinzino
Jan 26, 2026, 13:43 ET ZINZINO AB (PUBL): Zinzino announces merger of It Works! into the Zinzino family of businesses for increased distribution power in North America and Europe
strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales.It Works!, is a globally renowned direct sales company in the
More news about: Zinzino
Jan 26, 2026, 10:49 ET 2026 Edition Of The Stanford Emerging Technology Review Offers Policymakers And Business Leaders New Insights Into The Implications Of Frontier Technologies
Amy Zegart."Breakthroughs in artificial intelligence, biotechnology, quantum science, advanced materials, and space technologies are reshaping economies, societies and geopolitics at breathtaking speed. Never before
More news about: Hoover Institution at Stanford University
Jan 26, 2026, 10:16 ET Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
https://www.globenewswire.com/news-release/2026/01/20/3221521/0/en/Biotechnology-Market-Size-to-Surpass-USD-9-06-Trillion-by-2035.htmlLogo:
More news about: Equity Insider
Jan 26, 2026, 10:01 ET Biomaterials Market worth $68.93 billion by 2030 | MarketsandMarkets™
(Germany).Browse Adjacent Markets: Biotechnology Market Research Reports & ConsultingRelated Reports:
More news about: MarketsandMarkets
Jan 26, 2026, 09:48 ET /C O R R E C T I O N -- SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD/
In the news release, Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's "Poetics of Time" Brand Positioning, issued Jan. 26, 2026 by SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD over PR Newswire, we are advised by the company that the description of WPP was incorrect.
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
Jan 26, 2026, 08:56 ET PLT Appoints Pritesh Shetty as Director of Business Development, APAC
for OmniActive Health Technologies.Mr. Shetty was awarded a Bachelor of Science degree in Biotechnology from SIES College (Mumbai University) and a Master of Business Administration in Biotechnology Marketing from the Savitribai Phule Pune University's Department of Management Sciences.About
More news about: PLT Health Solutions
Jan 26, 2026, 08:50 ET Draper Awarded Part of Defense Microelectronics Contract Worth Up to $25 Billion
meet our customers' requirements. These efforts focus on four critical mission areas: Strategic Systems, Space Systems, Electronic Systems, and Biotechnology Systems. To extend our legacy into the future, the
More news about: Draper Laboratory
Jan 26, 2026, 08:30 ET Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium
an emerging biotechnology company focused on identifying genetically modified cells lines, and through joint venture and licensing agreements developing innovative cell-based therapies.About SGAustria Pte. Ltd.SGAustria, based in Singapore, is a leading biotechnology company specializing
More news about: Avant Technologies Inc.